Julia Cadanet-Blay
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families.
Journal: Redox biology
Published: March 04, 2026
Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium.
Journal: iScience
Published: June 30, 2021
Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages.
Journal: Nature metabolism
Published: May 19, 2021
Cellular Metabolites Regulate Central Nucleic Acid Sensing Pathways.
Journal: Frontiers in immunology
Published: November 30, 2020
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Journal: Nature communications
Published: October 22, 2020
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.
Journal: Antiviral research
Published: July 22, 2020
SARS-CoV-2 evades immune detection in alveolar macrophages.
Journal: EMBO reports
Published: July 07, 2020
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Journal: Nature communications
Published: May 14, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026